Enhancement of sensitivity of urinary bladder tumor cells to cisplatin by c-myc antisense oligonucleotide
Open Access
- 1 November 1994
- Vol. 74 (9) , 2546-2554
- https://doi.org/10.1002/1097-0142(19941101)74:9<2546::aid-cncr2820740924>3.0.co;2-y
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Overcoming tumor necrosis factor-α resistance of human renal and ovarian carcinoma cells by combination treatment with buthionine sulfoximine and tumor necrosis factor-α. Role of tumor necrosis factor-α mRNA down-regulation in tumor cell sensitizationCancer, 1994
- Hierarchy of in vitro sensitivity and resistance of tumor cells to cytotoxic effector cells, cytokines, drugs and toxinsCancer Immunology, Immunotherapy, 1992
- Detection of the c‐myc Gene Product in Urinary Bladder CancerJapanese Journal of Cancer Research, 1990
- Oncogenes and germ cell tumoursInternational Journal of Andrology, 1987
- Glutathione depletion reverses cisplatin resistance in murine L1210 leukemia cells☆Cancer Letters, 1987
- Evaluating and designing cancer chemotherapy treatment using mathematical modelsEuropean Journal of Cancer and Clinical Oncology, 1986
- Nuclear Localization and DNA Binding Properties of a Protein Expressed by Human c- myc OncogeneScience, 1984
- Amplification and expression of the c-myc oncogene in human lung cancer cell linesNature, 1983
- The role of DNA repair in the recovery of human cells from cisplatin toxicityChemico-Biological Interactions, 1981
- Effects of cis-dichlorodiammine platinum (II) on DNA synthesis in kidney and other tissues of normal and tumour-bearing ratsPublished by Elsevier ,1976